Loading clinical trials...

Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter | Clinical Trials | Clareo Health

COMPLETEDPhase 2

Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter

Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction With Radioiodine for the Treatment of Multinodular Goiter.

NCT00454220•Genzyme, a Sanofi Company

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Multinodular Goiter

Interventions

Placebo

MRrhTSH

+1 more

Locations

11

United States

Locations (11)

Boston, Massachusetts, United States

Curitiba, Brazil

Rio de Janeiro, Brazil

London, Ontario, Canada

Toronto, Canada

Odense, Denmark

Key Dates

Start Date

July 1, 2007

Primary Completion Date

July 1, 2011

Completion Date

July 1, 2011

Last Updated

June 7, 2022

Related Studies

Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy

NCT07395388

Benign Multinodular GoiterThyroidectomy+2 more

Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery

NCT05774535

Plummer DiseaseMultinodular Goiter+5 more

Sponsors

Lead Sponsor

Genzyme, a Sanofi Company

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 7, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions